QuantRx Biomedical Corporation (QTXB)
USD 0.0
(400.0%)
USD 0.0
(400.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 1978.00 USD | -22.85% |
| 2012 | 2564.00 USD | -11.89% |
| 2011 | 2910.00 USD | -22.81% |
| 2010 | 3770.00 USD | -19.46% |
| 2009 | 4681.00 USD | -88.34% |
| 2008 | 40.13 Thousand USD | 7.57% |
| 2007 | 37.31 Thousand USD | -67.09% |
| 2006 | 113.38 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 40 Thousand USD | -42.86% |
| 1999 | 70 Thousand USD | 0.0% |
| 1998 | 70 Thousand USD | -58.82% |
| 1997 | 170 Thousand USD | -10.53% |
| 1996 | 190 Thousand USD | 18.75% |
| 1995 | 160 Thousand USD | 300.0% |
| 1994 | 40 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | 16.57 Thousand USD | -59.43% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q3 | 446.00 USD | -59.49% |
| 2014 Q2 | 1101.00 USD | -36.58% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | 40.86 Thousand USD | 9061.66% |
| 2014 Q1 | 1736.00 USD | -12.23% |
| 2013 FY | 1978.00 USD | -22.85% |
| 2013 Q1 | 2483.00 USD | -3.16% |
| 2013 Q2 | 2306.00 USD | -7.13% |
| 2013 Q3 | 2076.00 USD | -9.97% |
| 2013 Q4 | 1978.00 USD | -4.72% |
| 2012 Q1 | 2712.00 USD | -6.8% |
| 2012 Q3 | 2590.00 USD | -3.75% |
| 2012 Q4 | 2564.00 USD | -1.0% |
| 2012 FY | 2564.00 USD | -11.89% |
| 2012 Q2 | 2691.00 USD | -0.77% |
| 2011 FY | 2910.00 USD | -22.81% |
| 2011 Q4 | 2910.00 USD | -2.38% |
| 2011 Q3 | 2981.00 USD | -1.91% |
| 2011 Q2 | 3039.00 USD | -3.19% |
| 2011 Q1 | 3139.00 USD | -16.74% |
| 2010 Q2 | 4578.00 USD | -2.07% |
| 2010 Q4 | 3770.00 USD | -13.91% |
| 2010 FY | 3770.00 USD | -19.46% |
| 2010 Q3 | 4379.00 USD | -4.35% |
| 2010 Q1 | 4675.00 USD | -0.13% |
| 2009 Q3 | 4778.00 USD | -87.6% |
| 2009 Q1 | 38.7 Thousand USD | -3.58% |
| 2009 FY | 4681.00 USD | -88.34% |
| 2009 Q4 | 4681.00 USD | -2.03% |
| 2009 Q2 | 38.54 Thousand USD | -0.41% |
| 2008 Q4 | 40.13 Thousand USD | -42.16% |
| 2008 Q1 | 40.44 Thousand USD | 8.39% |
| 2008 Q2 | 48.16 Thousand USD | 19.09% |
| 2008 Q3 | 69.39 Thousand USD | 44.08% |
| 2008 FY | 40.13 Thousand USD | 7.57% |
| 2007 Q3 | -300 Thousand USD | -311.46% |
| 2007 Q4 | 37.31 Thousand USD | 112.44% |
| 2007 Q2 | 141.86 Thousand USD | 115.76% |
| 2007 FY | 37.31 Thousand USD | -67.09% |
| 2007 Q1 | -900 Thousand USD | -893.75% |
| 2006 FY | 113.38 Thousand USD | 0.0% |
| 2006 Q1 | 58.18 Thousand USD | 0.0% |
| 2006 Q2 | 253.5 Thousand USD | 335.71% |
| 2006 Q3 | 225.31 Thousand USD | -11.12% |
| 2006 Q4 | 113.38 Thousand USD | -49.68% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | -100.0% |
| 2001 Q1 | 40 Thousand USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 40 Thousand USD | 0.0% |
| 2001 Q2 | 40 Thousand USD | 0.0% |
| 2000 Q2 | 50 Thousand USD | -16.67% |
| 2000 Q4 | 40 Thousand USD | -20.0% |
| 2000 Q3 | 50 Thousand USD | 0.0% |
| 2000 Q1 | 60 Thousand USD | -14.29% |
| 2000 FY | 40 Thousand USD | -42.86% |
| 1999 Q2 | 80 Thousand USD | 14.29% |
| 1999 Q1 | 70 Thousand USD | 0.0% |
| 1999 Q3 | 70 Thousand USD | -12.5% |
| 1999 Q4 | 70 Thousand USD | 0.0% |
| 1999 FY | 70 Thousand USD | 0.0% |
| 1998 FY | 70 Thousand USD | -58.82% |
| 1998 Q3 | 100 Thousand USD | -44.44% |
| 1998 Q2 | 180 Thousand USD | 12.5% |
| 1998 Q4 | 70 Thousand USD | -30.0% |
| 1998 Q1 | 160 Thousand USD | -5.88% |
| 1997 Q3 | 100 Thousand USD | 150.0% |
| 1997 Q4 | 170 Thousand USD | 70.0% |
| 1997 Q2 | 40 Thousand USD | -78.95% |
| 1997 Q1 | 190 Thousand USD | 0.0% |
| 1997 FY | 170 Thousand USD | -10.53% |
| 1996 Q3 | 360 Thousand USD | -7.69% |
| 1996 Q1 | 330 Thousand USD | 106.25% |
| 1996 FY | 190 Thousand USD | 18.75% |
| 1996 Q2 | 390 Thousand USD | 18.18% |
| 1996 Q4 | 190 Thousand USD | -47.22% |
| 1995 Q4 | 160 Thousand USD | 77.78% |
| 1995 Q1 | 70 Thousand USD | 75.0% |
| 1995 Q2 | 60 Thousand USD | -14.29% |
| 1995 Q3 | 90 Thousand USD | 50.0% |
| 1995 FY | 160 Thousand USD | 300.0% |
| 1994 FY | 40 Thousand USD | 0.0% |
| 1994 Q3 | 10 Thousand USD | 0.0% |
| 1994 Q2 | 10 Thousand USD | 0.0% |
| 1994 Q4 | 40 Thousand USD | 300.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | 100.0% |
| Ansell Limited | 457.04 Million USD | 100.0% |
| Ansell Limited | 457.9 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 43.33 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 27.89 Thousand USD | 100.0% |
| Psykey, Inc. | 49.94 Thousand USD | 100.0% |
| ConvaTec Group Plc | 395.54 Million USD | 100.0% |
| ConvaTec Group Plc | 396.1 Million USD | 100.0% |
| Encision Inc. | 1.4 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | -9294.00 USD | 100.0% |
| LifePoint, Inc. | 2.3 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | 100.0% |
| Remedent, Inc. | 91.88 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 49.87 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 100.0% |
| SheerVision, Inc. | 339.66 Thousand USD | 100.0% |
| United Health Products, Inc. | 33.59 Thousand USD | 100.0% |
| Vasamed, Inc. | 449.02 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 8555.00 USD | 100.0% |
| Yubo International Biotech Limited | 322.17 Thousand USD | 100.0% |